About KALEIDOSCOPEDX, INC.
KaleidoscopeDx is a diagnostics company developing urine-based tests to detect disease early, before symptoms appear, using multiomic analysis and AI-driven insights. Their platform focuses on non-invasive sampling and early disease detection through molecular biomarkers.
Multiomic analysis of DNA, RNA, proteins, and metabolitesNon-invasive sampling using urine and stoolEarly disease detection before symptoms appearHigh-sensitivity assays with real-world turnaround timesAI and machine learning for pattern recognition in complex molecular dataFlexible platform for expansion into new disease areas
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KALEIDOSCOPEDX, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.